+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Thyroid Gland Disorder Treatment Market 2023-2027

  • PDF Icon

    Report

  • 155 Pages
  • July 2023
  • Region: Global
  • TechNavio
  • ID: 5188691
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The thyroid gland disorder treatment market is forecasted to grow by USD 868.87 mn during 2022-2027, accelerating at a CAGR of 5.33% during the forecast period. The report on the thyroid gland disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in thyroid treatment awareness programs globally, increasing demand for levothyroxine, and growing patient population with iodine deficiency.

The thyroid gland disorder treatment market is segmented as below:

By Type

  • Hypothyroidism
  • Hyperthyroidism

By Distribution Channel

  • Offline
  • Online

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising focus on emerging economies as one of the prime reasons driving the thyroid gland disorder treatment market growth during the next few years. Also, increased outsourcing of non-core activities and growing focus on natural drugs will lead to sizable demand in the market.

The report on the thyroid gland disorder treatment market covers the following areas:

  • Thyroid gland disorder treatment market sizing
  • Thyroid gland disorder treatment market forecast
  • Thyroid gland disorder treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading thyroid gland disorder treatment market vendors that include Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Exelixis Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, IBSA Institute Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., Lannett Co. Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., RLC Labs Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the thyroid gland disorder treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global thyroid gland disorder treatment market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global thyroid gland disorder treatment market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Hypothyroidism - Market size and forecast 2022-2027
Exhibit 34: Chart on Hypothyroidism - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hypothyroidism - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hypothyroidism - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Hypothyroidism - Year-over-year growth 2022-2027 (%)
6.4 Hyperthyroidism - Market size and forecast 2022-2027
Exhibit 38: Chart on Hyperthyroidism - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Hyperthyroidism - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Hyperthyroidism - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hyperthyroidism - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2022-2027
Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
7.4 Online - Market size and forecast 2022-2027
Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ million)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 112: AbbVie Inc. - Overview
Exhibit 113: AbbVie Inc. - Product/Service
Exhibit 114: AbbVie Inc. - Key news
Exhibit 115: AbbVie Inc. - Key offerings
12.5 Alvogen Iceland ehf
Exhibit 116: Alvogen Iceland ehf - Overview
Exhibit 117: Alvogen Iceland ehf - Product/Service
Exhibit 118: Alvogen Iceland ehf - Key offerings
12.6 Exelixis Inc.
Exhibit 119: Exelixis Inc. - Overview
Exhibit 120: Exelixis Inc. - Product/Service
Exhibit 121: Exelixis Inc. - Key offerings
12.7 Fresenius SE and Co. KGaA
Exhibit 122: Fresenius SE and Co. KGaA - Overview
Exhibit 123: Fresenius SE and Co. KGaA - Business segments
Exhibit 124: Fresenius SE and Co. KGaA - Key news
Exhibit 125: Fresenius SE and Co. KGaA - Key offerings
Exhibit 126: Fresenius SE and Co. KGaA - Segment focus
12.8 GlaxoSmithKline Plc
Exhibit 127: GlaxoSmithKline Plc - Overview
Exhibit 128: GlaxoSmithKline Plc - Business segments
Exhibit 129: GlaxoSmithKline Plc - Key news
Exhibit 130: GlaxoSmithKline Plc - Key offerings
Exhibit 131: GlaxoSmithKline Plc - Segment focus
12.9 JEROME STEVENS PHARMACEUTICALS INC.
Exhibit 132: JEROME STEVENS PHARMACEUTICALS INC. - Overview
Exhibit 133: JEROME STEVENS PHARMACEUTICALS INC. - Product/Service
Exhibit 134: JEROME STEVENS PHARMACEUTICALS INC. - Key offerings
12.10 Lannett Co. Inc.
Exhibit 135: Lannett Co. Inc. - Overview
Exhibit 136: Lannett Co. Inc. - Product/Service
Exhibit 137: Lannett Co. Inc. - Key offerings
12.11 Lupin Ltd.
Exhibit 138: Lupin Ltd. - Overview
Exhibit 139: Lupin Ltd. - Product/Service
Exhibit 140: Lupin Ltd. - Key news
Exhibit 141: Lupin Ltd. - Key offerings
12.12 Mayne Pharma Group Ltd.
Exhibit 142: Mayne Pharma Group Ltd. - Overview
Exhibit 143: Mayne Pharma Group Ltd. - Business segments
Exhibit 144: Mayne Pharma Group Ltd. - Key news
Exhibit 145: Mayne Pharma Group Ltd. - Key offerings
Exhibit 146: Mayne Pharma Group Ltd. - Segment focus
12.13 Merck KGaA
Exhibit 147: Merck KGaA - Overview
Exhibit 148: Merck KGaA - Business segments
Exhibit 149: Merck KGaA - Key news
Exhibit 150: Merck KGaA - Key offerings
Exhibit 151: Merck KGaA - Segment focus
12.14 Novartis AG
Exhibit 152: Novartis AG - Overview
Exhibit 153: Novartis AG - Business segments
Exhibit 154: Novartis AG - Key offerings
Exhibit 155: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product/Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.16 RLC Labs Inc.
Exhibit 160: RLC Labs Inc. - Overview
Exhibit 161: RLC Labs Inc. - Product/Service
Exhibit 162: RLC Labs Inc. - Key offerings
12.17 Viatris Inc.
Exhibit 163: Viatris Inc. - Overview
Exhibit 164: Viatris Inc. - Business segments
Exhibit 165: Viatris Inc. - Key news
Exhibit 166: Viatris Inc. - Key offerings
Exhibit 167: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 168: Inclusions checklist
Exhibit 169: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 170: Currency conversion rates for US$
13.4 Research methodology
Exhibit 171: Research methodology
Exhibit 172: Validation techniques employed for market sizing
Exhibit 173: Information sources
13.5 List of abbreviations
Exhibit 174: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global thyroid gland disorder treatment market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Hypothyroidism - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Hypothyroidism - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Hypothyroidism - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Hypothyroidism - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Hyperthyroidism - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Hyperthyroidism - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Hyperthyroidism - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Hyperthyroidism - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ million)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ million)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 101: Impact of drivers and challenges in 2022 and 2027
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Abbott Laboratories - Overview
Exhibits 108: Abbott Laboratories - Business segments
Exhibits 109: Abbott Laboratories - Key news
Exhibits 110: Abbott Laboratories - Key offerings
Exhibits 111: Abbott Laboratories - Segment focus
Exhibits 112: AbbVie Inc. - Overview
Exhibits 113: AbbVie Inc. - Product/Service
Exhibits 114: AbbVie Inc. - Key news
Exhibits 115: AbbVie Inc. - Key offerings
Exhibits 116: Alvogen Iceland ehf - Overview
Exhibits 117: Alvogen Iceland ehf - Product/Service
Exhibits 118: Alvogen Iceland ehf - Key offerings
Exhibits 119: Exelixis Inc. - Overview
Exhibits 120: Exelixis Inc. - Product/Service
Exhibits 121: Exelixis Inc. - Key offerings
Exhibits 122: Fresenius SE and Co. KGaA - Overview
Exhibits 123: Fresenius SE and Co. KGaA - Business segments
Exhibits 124: Fresenius SE and Co. KGaA - Key news
Exhibits 125: Fresenius SE and Co. KGaA - Key offerings
Exhibits 126: Fresenius SE and Co. KGaA - Segment focus
Exhibits 127: GlaxoSmithKline Plc - Overview
Exhibits 128: GlaxoSmithKline Plc - Business segments
Exhibits 129: GlaxoSmithKline Plc - Key news
Exhibits 130: GlaxoSmithKline Plc - Key offerings
Exhibits 131: GlaxoSmithKline Plc - Segment focus
Exhibits 132: JEROME STEVENS PHARMACEUTICALS INC. - Overview
Exhibits 133: JEROME STEVENS PHARMACEUTICALS INC. - Product/Service
Exhibits 134: JEROME STEVENS PHARMACEUTICALS INC. - Key offerings
Exhibits 135: Lannett Co. Inc. - Overview
Exhibits 136: Lannett Co. Inc. - Product/Service
Exhibits 137: Lannett Co. Inc. - Key offerings
Exhibits 138: Lupin Ltd. - Overview
Exhibits 139: Lupin Ltd. - Product/Service
Exhibits 140: Lupin Ltd. - Key news
Exhibits 141: Lupin Ltd. - Key offerings
Exhibits 142: Mayne Pharma Group Ltd. - Overview
Exhibits 143: Mayne Pharma Group Ltd. - Business segments
Exhibits 144: Mayne Pharma Group Ltd. - Key news
Exhibits 145: Mayne Pharma Group Ltd. - Key offerings
Exhibits 146: Mayne Pharma Group Ltd. - Segment focus
Exhibits 147: Merck KGaA - Overview
Exhibits 148: Merck KGaA - Business segments
Exhibits 149: Merck KGaA - Key news
Exhibits 150: Merck KGaA - Key offerings
Exhibits 151: Merck KGaA - Segment focus
Exhibits 152: Novartis AG - Overview
Exhibits 153: Novartis AG - Business segments
Exhibits 154: Novartis AG - Key offerings
Exhibits 155: Novartis AG - Segment focus
Exhibits 156: Pfizer Inc. - Overview
Exhibits 157: Pfizer Inc. - Product/Service
Exhibits 158: Pfizer Inc. - Key news
Exhibits 159: Pfizer Inc. - Key offerings
Exhibits 160: RLC Labs Inc. - Overview
Exhibits 161: RLC Labs Inc. - Product/Service
Exhibits 162: RLC Labs Inc. - Key offerings
Exhibits 163: Viatris Inc. - Overview
Exhibits 164: Viatris Inc. - Business segments
Exhibits 165: Viatris Inc. - Key news
Exhibits 166: Viatris Inc. - Key offerings
Exhibits 167: Viatris Inc. - Segment focus
Exhibits 168: Inclusions checklist
Exhibits 169: Exclusions checklist
Exhibits 170: Currency conversion rates for US$
Exhibits 171: Research methodology
Exhibits 172: Validation techniques employed for market sizing
Exhibits 173: Information sources
Exhibits 174: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global thyroid gland disorder treatment market: Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, Amgen Inc., Exelixis Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, IBSA Institute Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., Lannett Co. Inc., Lupin Ltd., Mayne Pharma Group Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Piramal Enterprises Ltd., RLC Labs Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising focus on emerging economies.'

According to the report, one of the major drivers for this market is the rise in thyroid treatment awareness programs globally.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Alvogen Iceland ehf
  • Amgen Inc.
  • Exelixis Inc.
  • Fresenius SE and Co. KGaA
  • GlaxoSmithKline Plc
  • IBSA Institute Biochimique SA
  • JEROME STEVENS PHARMACEUTICALS INC.
  • Lannett Co. Inc.
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • RLC Labs Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Viatris Inc.